Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
The return on assets (ROA) is -902.18%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -272.18%.
RETURN ON ASSETS (ROA)
-902.18%
RETURN ON ASSETS (ROA) AVG TTM
N/A
RETURN ON ASSETS (ROA) AVG 3Y
N/A
RETURN ON ASSETS (ROA) AVG 5Y
N/A
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-31.75%
median of 809 covered companies
CURRENT VS SECTOR MEDIAN
-2741.51%
vs the sector median at left
Neonc Technologies Holdings, Inc.
Market Cap
$77.21M
Return on Assets (ROA)
-902.18%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$77.53M
Return on Assets (ROA)
-38.31%
TTM Avg
-38.33%
3Y Avg
-38.15%
5Y Avg
-51.76%
Market Cap
$76.64M
Return on Assets (ROA)
-55.32%
TTM Avg
-66.75%
3Y Avg
-58.76%
5Y Avg
-49.95%
Market Cap
$76.14M
Return on Assets (ROA)
-5.84%
TTM Avg
-3.07%
3Y Avg
-3.13%
5Y Avg
-9.45%
Market Cap
$78.35M
Return on Assets (ROA)
-41.94%
TTM Avg
-38.20%
3Y Avg
-35.26%
5Y Avg
-28.99%
Market Cap
$78.76M
Return on Assets (ROA)
-136.52%
TTM Avg
-104.53%
3Y Avg
-92.09%
5Y Avg
-76.74%
Market Cap
$75.63M
Return on Assets (ROA)
-30.65%
TTM Avg
-38.63%
3Y Avg
-43.27%
5Y Avg
-38.60%
Market Cap
$79.96M
Return on Assets (ROA)
-41.09%
TTM Avg
-24.80%
3Y Avg
-25.41%
5Y Avg
-25.41%
Market Cap
$80.59M
Return on Assets (ROA)
-110.64%
TTM Avg
-124.68%
3Y Avg
-93.30%
5Y Avg
-78.61%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Neonc Technologies Holdings, Inc. (NTHI) | $77.21M | -902.18% | N/A | N/A | N/A |
| Sera Prognostics, Inc. (SERA)vs › | $77.53M | -38.31% | -38.33% | -38.15% | -51.76% |
| Hyperfine, Inc. (HYPR)vs › | $76.64M | -55.32% | -66.75% | -58.76% | -49.95% |
| SkinHealth Systems Inc. (SKIN)vs › | $76.14M | -5.84% | -3.07% | -3.13% | -9.45% |
| Pulmonx Corporation (LUNG)vs › | $78.35M | -41.94% | -38.20% | -35.26% | -28.99% |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $78.76M | -136.52% | -104.53% | -92.09% | -76.74% |
| Outset Medical, Inc. (OM)vs › | $75.63M | -30.65% | -38.63% | -43.27% | -38.60% |
| Citius Oncology, Inc. (CTOR)vs › | $79.96M | -41.09% | -24.80% | -25.41% | -25.41% |
| Nutriband Inc. (NTRB)vs › | $80.59M | -110.64% | -124.68% | -93.30% | -78.61% |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $80.90M | -74.91% | -50.52% | -40.48% | -70.00% |
ROA
-902.2%
ROE
N/A
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -2200.93% |
